Kate Stalter, Contributing Author at MarketBeat

Articles by Kate Stalter - Page 4

January 8, 2024 5:30 AM ET

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

Kate Stalter

HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.

NYSE:HCANASDAQ:DXCMNYSE:LLY

January 8, 2024 5:03 AM ET

IPO watch 2024: Which new stocks will hit the market?

Kate Stalter

Expectations are high for the 2024 IPO market, with Reddit, Databricks, and Shein debuts anticipated, hinting at a substantial influx of new public companies.

NASDAQ:APGENASDAQ:CARTNASDAQ:GPCR

January 6, 2024 5:50 AM ET

Are defensive sectors ready to outshine growth in 2024?

Kate Stalter

Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead.

NYSE:MONASDAQ:AZNNYSEARCA:XLP

January 5, 2024 9:20 AM ET

Rare chart pattern setting up 3 stocks for upside trade

Kate Stalter

Axon, MercadoLibre, and e.l.f. Beauty pulled back with the broad market, yet still hold potential for gains following a rare three-weeks-tight trading pattern.

NASDAQ:AAPLNASDAQ:AXONNYSEARCA:ILF

January 5, 2024 7:23 AM ET

Are top upgrades Micron, Lululemon & CrowdStrike buys right now?

Kate Stalter

Micron, Lululemon, and CrowdStrike top MarketBeat's list of most upgraded stocks. All three posted strong 2023 rallies and are pulling back in the new year.

NASDAQ:LULUNASDAQ:MUNASDAQ:CRWD

January 5, 2024 5:15 AM ET

Hidden gems: 3 undervalued stocks with a unique competitive edge

Kate Stalter

Etsy, International Flavors & Fragrances and Zimmer Biomet are undervalued stocks with unique market advantages. Patient investors may find opportunities here.

NASDAQ:ETSYNYSE:IFFNYSEARCA:XLB

January 4, 2024 8:21 AM ET

Is the January Effect reliable indicator for yearly performance?

Kate Stalter

The January Effect refers to January’s market return as predictive of the full year. But is January's performance truly an indicator of how the year may go?

NASDAQ:AAPLNASDAQ:MUNYSE:NCLH

January 4, 2024 5:00 AM ET

2024 stock watch: The Magnificent 7's role In market performance

Kate Stalter

While market dynamics may be different in 2024, analysts say many of 2023's Magnificent 7 leading stocks may show outstanding performance again this year.

NASDAQ:GOOGLNASDAQ:AMZNNASDAQ:AAPL

January 3, 2024 5:00 AM ET

Cathie Wood readies portfolio as Bitcoin ETF decision nears

Kate Stalter

As Bitcoin hits a two-year peak, Ark fund manager Cathie Wood makes strategic portfolio changes ahead of regulators' decision on the first spot Bitcoin ETF.

NASDAQ:COINNYSEARCA:ARKKNYSEARCA:XLF

December 29, 2023 9:49 AM ET

Celsius stock in actionable zone as big investors ramp up buying

Kate Stalter

Celsius gained momentum in the last trading days of 2023 after a November pullback. Celsius' growth is fueled by strong revenue and support from backer PepsiCo.

NASDAQ:CELHNYSEARCA:XLPNASDAQ:MNST

December 29, 2023 7:32 AM ET

Microsoft is new cybersecurity titan, challenging big tech rivals

Kate Stalter

Microsoft is a key player in cybersecurity, competing with companies such as CrowdStrike and Amazon. Its annual cybersecurity business grew to $20 billion.

NASDAQ:MSFTNASDAQ:GOOGLNASDAQ:AMZN

December 29, 2023 6:45 AM ET

Cruise lines navigate from worst to first in 2023 surge

Kate Stalter

The cruise industry has transformed itself, led by Royal Caribbean, Carnival and Norwegian. Companies focus on affordable pricing and higher profit margins.

NYSE:CCLNYSEARCA:XLYNYSE:NCLH

December 29, 2023 6:41 AM ET

Small-cap surge: Outpacing large caps on hopes for '24 rate cuts

Kate Stalter

Small-cap stocks surged past large caps recently, fueled by lower interest rates and renewed economic confidence. Small growth and value are both rallying.

NYSE:MTHNASDAQ:SPSCNYSEARCA:SPY

December 29, 2023 6:40 AM ET

Synopsys stock: Unsung hero of the AI revolution

Kate Stalter

Synopsis, the leading provider of electronic design automation software, is up more than 60% in 2023 as customers AMD, Nvidia and Intel expand AI capabilities.

NASDAQ:SNPSNASDAQ:ALTRNASDAQ:ANSS

December 29, 2023 6:39 AM ET

Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals

Kate Stalter

Bristol Myers announced two acquisitions in a week. The pharma giant is boosting its neuroscience pipeline with Karuna and its oncology pipeline with RayzeBio.

NYSE:BMYNASDAQ:ITCINASDAQ:NBIX

December 29, 2023 6:28 AM ET

Apple stock is institutional favorite, but is it overvalued?

Kate Stalter

Despite a strong performance in 2023, the company's revenue and earnings growth are slowing. Should investors keep holding, or is the stock overvalued?

NASDAQ:AAPLNASDAQ:GOOGLNASDAQ:AMZN

December 28, 2023 4:15 AM ET

Will DoubleVerify form handle to offer early buy opportunity?

Kate Stalter

DoubleVerify roared back in November and December, forming the right side of a cup base; analysts recently increased their earnings forecasts for 2023 and 2024

NYSE:DVNASDAQ:GOOGLNYSE:HUBS

December 27, 2023 9:23 AM ET

Synopsys offers to acquire Ansys, sparks stock surge

Kate Stalter

Ansys stock rose 18% on Synopsys acquisition news. Fellow engineering software maker Altair also rose on speculation it may be an acquisition target.

NASDAQ:ANSSNASDAQ:ALTRNASDAQ:ADSK

December 22, 2023 6:15 AM ET

Tesla's bold rally: Promising pattern as it overcomes roadblocks

Kate Stalter

Recent Tesla turbulence includes a cybertruck stuck in the snow and more serious safety recalls, yet its stock is forming a bullish double-bottom pattern.

NASDAQ:TSLANASDAQ:QQQNYSE:STLA

December 21, 2023 4:24 AM ET

Pfizer's chaotic year wraps up with plunging stock, grim guidance

Kate Stalter

Pfizer's tumultuous 2023 included a 41.84% stock plunge as revenue from Covid drugs fell. Disappointing 2024 guidance resulted in analysts slashing targets.

NYSE:PFENYSEARCA:XLVNASDAQ:MRNA

December 21, 2023 4:05 AM ET

US Steel forges ahead on news of $14.1 billion acquisition

Kate Stalter

US Steel soared on Japanese giant Nippon Steel's $14.1 billion offer, which outbid Cleveland-Cliffs. Politicians and unions have concerns over the acquisition

NYSE:XNYSE:CLFNYSEARCA:XLB

December 20, 2023 5:24 AM ET

What should your portfolio look like in 2024?

Kate Stalter

Heading into 2024, declining interest rates are among factors that may send techs higher, though analysts cite the importance of broad diversification.

NASDAQ:GOOGLNASDAQ:AMZNNASDAQ:AAPL

December 18, 2023 5:05 AM ET

Semiconductor stocks soar on federal funding, hope for rate cuts

Kate Stalter

Semiconductor stocks, including Broadcom and ON Semi, surged after the White House released funding under the CHIPS Act. Hope for rate cuts also boosted chips.

OTCMKTS:BAESYNASDAQ:AVGONASDAQ:INTC

December 15, 2023 6:02 AM ET

Will the rally in crypto stocks continue into the new year?

Kate Stalter

Crypto stocks, including Coinbase and MicroStrategy, are surging on optimism about upcoming bitcoin ETFs, and hints of Federal Reserve interest rate cuts.

NASDAQ:COINNASDAQ:MARANASDAQ:RIOT

Page 4 of 37

« Most Recent ‹ More Recent 1 2 3 4 5 6 7 Earlier › Earliest »

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kate Stalter, Contributing Author at MarketBeat

Articles by Kate Stalter - Page 4

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

IPO watch 2024: Which new stocks will hit the market?

Are defensive sectors ready to outshine growth in 2024?

Rare chart pattern setting up 3 stocks for upside trade

Are top upgrades Micron, Lululemon & CrowdStrike buys right now?

Hidden gems: 3 undervalued stocks with a unique competitive edge

Is the January Effect reliable indicator for yearly performance?

2024 stock watch: The Magnificent 7's role In market performance

Cathie Wood readies portfolio as Bitcoin ETF decision nears

Celsius stock in actionable zone as big investors ramp up buying

Microsoft is new cybersecurity titan, challenging big tech rivals

Cruise lines navigate from worst to first in 2023 surge

Small-cap surge: Outpacing large caps on hopes for '24 rate cuts

Synopsys stock: Unsung hero of the AI revolution

Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals

Apple stock is institutional favorite, but is it overvalued?

Will DoubleVerify form handle to offer early buy opportunity?

Synopsys offers to acquire Ansys, sparks stock surge

Tesla's bold rally: Promising pattern as it overcomes roadblocks

Pfizer's chaotic year wraps up with plunging stock, grim guidance

US Steel forges ahead on news of $14.1 billion acquisition

What should your portfolio look like in 2024?

Semiconductor stocks soar on federal funding, hope for rate cuts

Will the rally in crypto stocks continue into the new year?

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kate Stalter, Contributing Author at MarketBeat

Articles by Kate Stalter - Page 4

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

IPO watch 2024: Which new stocks will hit the market?

Are defensive sectors ready to outshine growth in 2024?

Rare chart pattern setting up 3 stocks for upside trade

Are top upgrades Micron, Lululemon & CrowdStrike buys right now?

Hidden gems: 3 undervalued stocks with a unique competitive edge

Is the January Effect reliable indicator for yearly performance?

2024 stock watch: The Magnificent 7's role In market performance

Cathie Wood readies portfolio as Bitcoin ETF decision nears

Celsius stock in actionable zone as big investors ramp up buying

Microsoft is new cybersecurity titan, challenging big tech rivals

Cruise lines navigate from worst to first in 2023 surge

Small-cap surge: Outpacing large caps on hopes for '24 rate cuts

Synopsys stock: Unsung hero of the AI revolution

Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals

Apple stock is institutional favorite, but is it overvalued?

Will DoubleVerify form handle to offer early buy opportunity?

Synopsys offers to acquire Ansys, sparks stock surge

Tesla's bold rally: Promising pattern as it overcomes roadblocks

Pfizer's chaotic year wraps up with plunging stock, grim guidance

US Steel forges ahead on news of $14.1 billion acquisition

What should your portfolio look like in 2024?

Semiconductor stocks soar on federal funding, hope for rate cuts

Will the rally in crypto stocks continue into the new year?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools